Info@ThinkPinkRocks.com

Neuronetrix announces FDA approval of COGNISION System for clinical use

Neuronetrix today announced that it has received 510(k) clearance (K141316) from the United States Food and Drug Administration to market the COGNISION System for clinical use.

Read the original post:
Neuronetrix announces FDA approval of COGNISION System for clinical use

Share

Leave a Reply

Solve : *
8 − 1 =